CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

GSK third quarter likely to be in line as RBC sees vaccine headwinds offset by HIV strength

EarningsNeutral
AI Analysis

Summary

RBC Capital Markets expects GSK's third quarter results to be in line with guidance, with vaccine segment headwinds offset by strength in HIV product sales.

Financial Highlights

Guidance

in line

Importance:4/10
Sentiment:
0.00
earningsvaccinesHIVQ3analyst_forecast
Related Companies

Read the original article

Published by yahoo_finance on October 13, 2026 2:24 PM

Read Original